Fesoterodine extended-release tablets recalled over a diester impurity above specification
Alembic Pharmaceuticals is recalling Fesoterodine Fumarate Extended-release Tablets, 8 mg, because levels of a diester impurity exceeded the specification limit.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Scored 2 under the rule that FDA Class III actions fall at 1 or 2: the record cites an impurity above specification with no stated clinical consequence.
Plain-English summary
Fesoterodine Fumarate Extended-release Tablets, 8 mg, 30 tablets, manufactured by Alembic Pharmaceuticals Limited of Panelav, Gujarat, India for Alembic Pharmaceuticals, Inc. of Bedminster, New Jersey, under NDC 62332-176-30, are being recalled.
The reason given in the enforcement record is failed impurities and degradation specifications, due to levels of the diester impurity exceeding the specification limit.
The recall covers lot 2405003360, expiry Jan 31, 2026. The record does not state a quantity. Distribution was nationwide in the United States and Puerto Rico. The FDA has classified the action as Class III, its least serious category.
Patients should not stop taking a prescribed medicine without speaking to their prescriber or pharmacist, who can confirm whether a specific bottle is affected and arrange a replacement.
The recalled product
- Product
- FESOTERODINE FUMARATE (FESOTERODINE FUMARATE)
- Brand
- FESOTERODINE FUMARATE
- Manufacturer
- Alembic Pharmaceuticals Limited
- Category
- Drug — Urological
- Hazard
- impurity
- out-of-specification
- class-iii
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot# 2405003360
- Exp Date: Jan 31
- 2026
UPCs (2)
- 0362332176304
- 0362332175307
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · FESOTERODINE FUMARATE
- ModerateFesoterodine tablets recalled after a diester impurity exceeded its specification limit
FDA (Drugs) · 2025-11-26
Same category
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22